| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | Options Exercise | $1.34M | +19.2K | +9.13% | $69.43 | 230K | 06 Jan 2022 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | -$1.34M | -14K | -6.06% | $95.76 | 216K | 06 Jan 2022 | Direct | |
| transaction | EOG | Common Stock | Tax liability | -$131K | -1.36K | -0.63% | $95.76 | 215K | 06 Jan 2022 | Direct | |
| transaction | EOG | Common Stock | Sale | -$376K | -3.93K | -1.83% | $95.79 | 211K | 06 Jan 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -19.2K | -100% | $0.00* | 0 | 06 Jan 2022 | Common Stock | 19.2K | $69.43 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs became exercisable in 25 percent increments beginning one year from the September 28, 2015 date of grant and on each of the next three grant date anniversaries. The SARs became fully exercisable on September 28, 2019. |